MX2019009469A - Composiciones y metodos para tratar alopecia. - Google Patents

Composiciones y metodos para tratar alopecia.

Info

Publication number
MX2019009469A
MX2019009469A MX2019009469A MX2019009469A MX2019009469A MX 2019009469 A MX2019009469 A MX 2019009469A MX 2019009469 A MX2019009469 A MX 2019009469A MX 2019009469 A MX2019009469 A MX 2019009469A MX 2019009469 A MX2019009469 A MX 2019009469A
Authority
MX
Mexico
Prior art keywords
treating alopecia
compositions
methods
humans
composition
Prior art date
Application number
MX2019009469A
Other languages
English (en)
Inventor
Weinstein David
Original Assignee
River Town Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by River Town Therapeutics Inc filed Critical River Town Therapeutics Inc
Publication of MX2019009469A publication Critical patent/MX2019009469A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/067—Radiation therapy using light using laser light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/0616—Skin treatment other than tanning
    • A61N5/0617—Hair treatment

Abstract

La presente invención se dirige a una composición para tratar la alopecia que contiene minoxidil, ciclosporina A y un compuesto que se une a la proteína 4 de unión FK506 4 adecuada para su administración a humanos; la presente invención se dirige además a tratar la alopecia en seres humanos mediante la administración de una composición de la invención.
MX2019009469A 2015-08-13 2018-02-13 Composiciones y metodos para tratar alopecia. MX2019009469A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562204799P 2015-08-13 2015-08-13
US201562272180P 2015-12-29 2015-12-29
US201662339398P 2016-05-20 2016-05-20

Publications (1)

Publication Number Publication Date
MX2019009469A true MX2019009469A (es) 2019-11-05

Family

ID=57984190

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2018001843A MX2018001843A (es) 2015-08-13 2016-08-10 Composiciones y metodos para tratar alopecia.
MX2019009469A MX2019009469A (es) 2015-08-13 2018-02-13 Composiciones y metodos para tratar alopecia.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2018001843A MX2018001843A (es) 2015-08-13 2016-08-10 Composiciones y metodos para tratar alopecia.

Country Status (7)

Country Link
US (4) US20170042859A1 (es)
EP (1) EP3334424B1 (es)
CA (1) CA2993829A1 (es)
ES (1) ES2828434T3 (es)
MX (2) MX2018001843A (es)
TW (1) TW201720434A (es)
WO (1) WO2017027564A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017165119A1 (en) * 2016-03-21 2017-09-28 David Weinstein Methods for wound healing and scar prevention

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2803692A (en) * 1991-10-11 1993-05-03 Vertex Pharmaceuticals Incorporated Isolation of an mr 52,000 fk506 binding protein and molecular cloning of a corresponding human cdna
US5639785A (en) * 1995-06-07 1997-06-17 Global Pharma, Ltd. Methods for the treatment of baldness and gray hair using isoflavonoid derivatives
US6187784B1 (en) * 1998-06-03 2001-02-13 Gpi Nil Holdings, Inc. Pipecolic acid derivative hair growth compositions and uses
US20010049381A1 (en) * 1997-06-04 2001-12-06 Gpl Nil Holdings, Inc., Pyrrolidine derivative hair growth compositions and uses
US6030948A (en) * 1997-12-19 2000-02-29 Mann; Morris A. Hair regeneration compositions for treatment of alopecia and methods of application related thereto
EP1842845B1 (en) 1998-06-03 2014-07-16 GliaMed, Inc. Aza-heterocyclic compounds used to treat neurological disorders and hair loss
JP2002516843A (ja) * 1998-06-03 2002-06-11 ジー・ピー・アイ ニイル ホールディングス インコーポレィティッド ヘテロサイクリックエステルおよびアミド発毛組成物およびその使用
US6331537B1 (en) * 1998-06-03 2001-12-18 Gpi Nil Holdings, Inc. Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
US6300341B1 (en) * 1998-09-30 2001-10-09 The Procter & Gamble Co. 2-substituted heterocyclic sulfonamides
KR100360716B1 (ko) * 2000-11-22 2002-11-13 주식회사 엘지생활건강 사이클로스포린 에이 7- 티오아미드 유도체를유효성분으로 하는 모발성장촉진제
US7189746B2 (en) * 2002-11-08 2007-03-13 Gliamed, Inc. Methods for promoting wound healing
US20050058614A1 (en) * 2003-09-15 2005-03-17 Allergan, Inc. Methods for the treatment of gray hair using cyclopentane(ene) heptan(en)oic acid amides
EP2242838A1 (en) * 2007-12-17 2010-10-27 GliaMed, Inc. Stem-like cells and method for reprogramming adult mammalian somatic cells
US10758630B2 (en) * 2010-08-13 2020-09-01 The Johns Hopkins University Topical compositions and methods of detection and treatment
CA2819859A1 (en) * 2010-12-06 2012-06-14 Follica, Inc. Methods for treating baldness and promoting hair growth
BR112013019519A2 (pt) * 2011-01-31 2016-08-09 Allergan Inc método de realce de crescimento capilar
US10285977B2 (en) * 2015-08-13 2019-05-14 David Weinstein Consulting, Inc. Compositions and methods for treating alopecia
WO2017165119A1 (en) * 2016-03-21 2017-09-28 David Weinstein Methods for wound healing and scar prevention

Also Published As

Publication number Publication date
US10363240B2 (en) 2019-07-30
WO2017027564A1 (en) 2017-02-16
TW201720434A (zh) 2017-06-16
US20180140577A1 (en) 2018-05-24
EP3334424A4 (en) 2019-04-24
CA2993829A1 (en) 2017-02-16
US20190216775A1 (en) 2019-07-18
US20200276157A1 (en) 2020-09-03
EP3334424B1 (en) 2020-10-14
US20170042859A1 (en) 2017-02-16
EP3334424A1 (en) 2018-06-20
MX2018001843A (es) 2018-05-16
ES2828434T3 (es) 2021-05-26

Similar Documents

Publication Publication Date Title
MY197635A (en) Benzooxazole derivatives as immunomodulators
MX2019002564A (es) Composiciones de agente de unión de albúmina-paclitaxel y métodos de uso y elaboración de las mismas.
PH12018500707A1 (en) Anti-human cd19 antibodies with high affinity
PH12018500642A1 (en) Anti-garp antibody
MX2019001125A (es) Inhibidores de cinasa macrociclica.
MY201925A (en) Macrocyclic compounds and uses thereof
PH12020550901A1 (en) Macrocyclic compounds for treating disease
EA201891083A1 (ru) Составы антител к cd38 для подкожного введения и их применение
MX2020009223A (es) Anticuerpos anti-fgfr2iiib afucosilados.
MX2018008052A (es) Inhibidores de desmetilasa especifica de lisina 1 (lsd1).
EA201891910A1 (ru) Гетероарильные ингибиторы pad4
MX2017016424A (es) Compuestos para su uso en el tratamiento de trastornos neuromusculares.
EA036102B9 (ru) Терапевтические средства с углевод-опосредованной адресной доставкой
MX2020006612A (es) Compuesto que funciona como inhibidor de proteína de bromodominio y composición.
NO20180002A1 (en) Aminobenzisoxazole compounds as agonists of A7-nicotinic acetylcholine receptors
NZ715582A (en) Lectin-like oxidized ldl receptor 1 antibodies and methods of use
MX2022002635A (es) Anticuerpos anti proteina similar a angiopoyetina 4 y metodos de uso.
TW201613977A (en) Angiopoetin-like 4 (ANGPTL4) antibodies and methods of use
SG10201907291QA (en) Monomethylfumarate prodrug compositions
MX366829B (es) Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas.
MX2019001634A (es) Compuestos amidas, composiciones farmacéuticas de estos y métodos para utilizarlos.
EA201792445A1 (ru) Новые амидогетероарилароилгидразидэтины
MX2019009469A (es) Composiciones y metodos para tratar alopecia.
MX2017007318A (es) Metodos de prevencion, reduccion o tratamiento de degeneracion macular.
MX2016004094A (es) Composicion farmaceutica que comprende capecitabina y ciclofosfamida.